免疫介导的血液溶解性贫血和血小板缺血的临床方法
1Rossdales Equine Hospital, Cotton End Road, Exning, Newmarket, Suffolk CB8 7NN, UK.
概括
马中的免疫媒介血液溶解性贫血 (IMHA) 和血小板缺血 (IMTP) 往往是其他疾病 (如瘤) 的次要原因. 及时诊断和谨慎的免疫抑制疗法是改善这些罕见的免疫相关血液疾病的关键.
科学领域:
- 兽医医学 兽医医学 兽医医学
- 免疫学 免疫学 免疫学
- 血液学 血液学 血液学
背景情况:
- 免疫媒介的血液溶解性贫血 (IMHA) 和免疫媒介的血小板缺血 (IMTP) 在马中不常见.
- 这些情况往往是潜在疾病的次要因素,瘤是显著的关联.
- 病例报告表明,癌症与免疫系统攻击红细胞和血小板之间存在联系.
研究的目的:
- 为了研究瘤和免疫介导的血液细胞破坏之间的关系,马.
- 强调诊断IMHA和IMTP的根本原因的重要性.
- 为了指导患有这些血液学疾病的马的治疗策略.
主要方法:
- 审查案例报告和有关马类IMHA和IMTP的现有文献.
- 对诊断方法进行分析,以确定二次原因.
- 评估治疗方案,包括免疫抑制疗法.
主要成果:
- 瘤是马中二次IMHA和IMTP的常见的潜在原因.
- 诊断工作应优先考虑排除感染和瘤.
- 当怀疑感染时,免疫抑制治疗需要仔细考虑.
结论:
- 马类IMHA和IMTP的有效管理需要识别和解决潜在的疾病,特别是瘤.
- 初级IMHA和IMTP病例与二次形式相比,一般呈现出更有利的预后.
- 治疗决策,特别是免疫抑制,必须考虑到潜在的并发感染.
相关概念视频
Blood Transfusion and Agglutination
10.8K
Blood transfusion is a therapeutic measure to restore the blood volume after extensive blood loss due to an accident or a medical procedure. Blood transfusion involves drawing a certain amount of blood from a suitable donor and infusing it into the recipient.
History
The history of blood transfusion dates back to the 17th century, when early attempts were made in animals. In 1818 James Blundell, a British doctor, performed the first successful human blood transfusion. Later in 1900, Karl...
History
The history of blood transfusion dates back to the 17th century, when early attempts were made in animals. In 1818 James Blundell, a British doctor, performed the first successful human blood transfusion. Later in 1900, Karl...
10.8K
Regulation of Hematopoietic Stem Cells
3.2K
All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
3.2K
Bone Marrow Sampling and Transplants
324
Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
324
Blood Transfusion
543
Blood transfusion is a critical medical procedure that saves lives and treats various medical conditions. It involves transferring blood from a donor to a recipient. This process requires a thorough understanding of the ABO blood group system and its associated antigens and antibodies.
Blood Transfusion Overview
A blood transfusion is a medical procedure used to replace blood lost due to injury, surgery, or to treat conditions such as anemia or cancer. During a transfusion, donor blood is...
Blood Transfusion Overview
A blood transfusion is a medical procedure used to replace blood lost due to injury, surgery, or to treat conditions such as anemia or cancer. During a transfusion, donor blood is...
543
Cytotoxic T Cells-mediated Immune Response
891
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
891
Disorders of Hemostasis
837
Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
837


